ALT vs CL · rev $20.0K vs P/E 34, rev $20.38B
Altimmune Inc (ALT) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
ALT currently screens at market cap $527.0M. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the ALT and CL stock pages for the full models.
Not investment advice.